Immuron Limited
IMRN
$1.92
$0.10855.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.32M | 3.78M | 3.22M | 2.78M | 2.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.32M | 3.78M | 3.22M | 2.78M | 2.36M |
| Cost of Revenue | 1.40M | 1.22M | 1.03M | 736.00K | 444.90K |
| Gross Profit | 2.91M | 2.56M | 2.19M | 2.05M | 1.92M |
| SG&A Expenses | 5.12M | 4.74M | 4.32M | 3.98M | 3.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.42M | -1.77M | -2.13M | -1.98M | -1.84M |
| Total Operating Expenses | 8.21M | 7.50M | 6.75M | 5.72M | 4.72M |
| Operating Income | -3.89M | -3.72M | -3.53M | -2.94M | -2.36M |
| Income Before Tax | -4.85M | -4.71M | -4.56M | -3.56M | -2.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.85 | -4.71 | -4.56 | -3.56 | -2.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.85M | -4.71M | -4.56M | -3.56M | -2.58M |
| EBIT | -3.89M | -3.72M | -3.53M | -2.94M | -2.36M |
| EBITDA | -3.89M | -3.72M | -3.53M | -2.93M | -2.35M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 912.90M | 912.17M | 911.44M | 911.32M | 911.19M |
| Average Diluted Shares Outstanding | 912.90M | 912.17M | 911.44M | 911.32M | 911.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |